Blood tests to get every year after 40 in India: the complete guide
- Seht Health Team

- May 7
- 6 min read

The blood tests every Indian adult should get every year after 40 expand significantly from earlier decades because this is when cardiovascular disease, diabetes, thyroid disorders, and cancers begin their steepest acceleration in the Indian population. After 40, CVD prevalence rises from 22% in the 45–54 age group to 38% by age 70. Yet most of these conditions are silent for years before causing a crisis. The following 16 annual blood tests, recommended for Indians above 40, form the early-detection system that makes that crisis preventable.
For a complete guide to family health checkup packages and costs, read: health checkup packages for family India 2026 (https://www.seht.in/post/health-checkup-packages-family-india-2026)
What you'll learn: • The 16 blood tests every Indian above 40 must get annually • Why each test matters specifically after 40 in Indian adults • Additional gender-specific tests for men and women over 40 • How often each test should be repeated based on results • Approximate costs at major Indian labs for the full panel |
Why the annual blood test panel expands after 40 in India

Before 40, a comprehensive blood panel primarily monitors for conditions that exist but may not yet have caused symptoms. After 40, the conditions you are screening for become significantly more probable, more dangerous, and more modifiable if caught early:
Cardiovascular risk doubles between ages 40 and 55 in Indian men, and rises sharply in women approaching menopause due to loss of oestrogen protection
Diabetes prevalence in Indian adults 40–59 is 2–3x higher than in those 25–39 and most cases are undiagnosed at first detection
Thyroid disorders particularly autoimmune thyroiditis peak in Indian women between ages 35 and 55
Prostate cancer risk in Indian men begins rising measurably after 45, making PSA testing relevant
Cervical and breast cancer risk rise significantly for women in the 40–55 decade without prior screening
The 16 essential blood tests after 40 for Indian adults
Test | Why it matters after 40 | Normal range | Frequency | Approx. cost (NABL lab) |
HbA1c | Diabetes risk accelerates sharply after 40 in Indians | Below 5.7% | Annually; 6-monthly if prediabetic | ₹250–₹500 |
Fasting blood glucose | Immediate blood sugar status alongside HbA1c | 70–99 mg/dL | Annually | ₹80–₹150 |
Full lipid profile (LDL, HDL, TG, Total) | Cardiovascular risk rises sharply; Indian lipid pattern worsens after 40 | LDL below 130; HDL above 40/50; TG below 150 | Annually | ₹300–₹600 |
CBC (Complete Blood Count) | Anaemia, infections, blood disorders, early leukaemia signs | Hb: M 13–17, F 12–15 g/dL | Annually | ₹150–₹350 |
TSH (Thyroid) | Thyroid disorders peak in Indian adults 40–55, especially women | 0.4–4.5 mIU/L | Annually; 6-monthly on thyroid medication | ₹200–₹400 |
Vitamin D (25-OH D) | Deficiency accelerates bone loss and cardiovascular risk after 40 | 30–100 ng/mL | Annually | ₹500–₹900 |
Vitamin B12 | Neurological decline risk rises with age; linked to dementia risk | 200–900 pg/mL | Annually | ₹300–₹600 |
Serum creatinine + eGFR | Kidney function: hypertension-driven damage is silent and common | Cr: M 0.74–1.35, F 0.59–1.04 mg/dL | Annually | ₹150–₹300 |
Urine albumin/creatinine ratio (microalbumin) | Early kidney damage from diabetes or hypertension detects damage 5–10 years before creatinine changes | Below 30 mg/g (normal) | Annually for diabetics and hypertensives | ₹200–₹400 |
LFT (Liver function tests) | NAFLD (fatty liver) prevalence rises sharply in Indian adults after 40 | ALT: M below 56, F below 45 IU/L | Annually | ₹250–₹500 |
Uric acid | Gout incidence rises significantly after 40; also cardiovascular risk marker | M: 3.5–7.2; F: 2.6–6.0 mg/dL | Annually | ₹100–₹200 |
Ferritin + iron studies | Iron deficiency persists in women until menopause; anaemia evaluation | Ferritin: 20–200 ng/mL women; 20–500 men | Annually women; every 2 years men | ₹400–₹700 |
hs-CRP (high-sensitivity CRP) | Chronic low-grade inflammation independent cardiovascular risk marker | Below 1.0 mg/L (low risk); 1–3 moderate | Annually from age 45 | ₹400–₹700 |
ECG (resting) | Cardiac electrical baseline: arrhythmias, LVH, silent ischaemia | Normal sinus rhythm, no ST changes | Annually from age 40 | ₹200–₹800 |
PSA (Prostate Specific Antigen) men only | Prostate cancer screening risk rises after 45 in Indian men | Below 4 ng/mL | Annually from age 45 | ₹300–₹600 |
FSH / LH / Oestradiol women approaching menopause | Perimenopause assessment; cardiovascular risk increases with oestrogen decline | Age and phase-dependent | From age 45 or at first irregular cycle | ₹600–₹1,200 |
In simple terms: Think of your annual blood tests after 40 like the MOT check for your car it's not about feeling fine or not, it's about catching wear before it becomes breakdown. Your HbA1c, lipids, creatinine, and TSH are your dashboard warning lights. Most Indian adults who discover they have diabetes, hypertension, or kidney disease over 40 felt perfectly fine until the test told them otherwise. |

Additional tests to consider after 45 the upgrade
After 45, the annual panel should be supplemented with tests whose risk has risen further:
Homocysteine: Elevated in 20–30% of Indian adults; independent cardiovascular risk; easily treated with B vitamins. Cost: ₹400–₹800.
ApoB / Lipoprotein(a): More accurate cardiovascular risk markers than LDL alone for Indians with borderline lipid profiles. Cost: ₹500–₹1,200.
Fasting insulin: Directly measures insulin resistance the root cause of type 2 diabetes and visceral fat in Indians. Cost: ₹300–₹700.
CA 19-9 / CA-125 (women) / AFP (if liver risk): Cancer markers discuss appropriateness with your doctor before ordering independently.
For understanding what your test results mean once you receive them, read: Normal blood test results explained for Indian patients (https://www.seht.in/post/normal-blood-test-results-explained-india)
Building your annual blood test calendar for the 40s in India
Month | Tests | Approximate cost | Notes |
January (annual) | HbA1c, FBG, full lipid profile, CBC, TSH, LFT, creatinine, urine microalbumin, Vitamin D, B12, uric acid, ferritin | ₹2,500–₹4,500 (comprehensive package) | Book at NABL lab; home collection available nationwide |
January (annual add-ons after 45) | hs-CRP, ECG, PSA (men 45+), fasting insulin | ₹1,500–₹2,500 additional | ECG at any hospital; blood tests at same lab visit |
July (mid-year, if managing chronic conditions) | HbA1c, creatinine, CBC | ₹700–₹1,000 | For those managing diabetes, hypertension, or anaemia |
Ongoing (home monitoring) | Blood pressure (home monitor), resting heart rate | ₹800–₹2,500 (one-time device cost) | Check BP morning and evening; track in Seht app |
When to see a doctor
HbA1c above 6.5% on any result confirms diabetes; requires specialist consultation immediately
PSA above 4.0 ng/mL for men above 45 requires urologist review; do not delay
LDL above 160 mg/dL alongside any other risk factor cardiologist consultation
Creatinine trending upward over 2+ consecutive years even within normal range
Vitamin D below 10 ng/mL severe deficiency requiring medical supervision
Emergency: Sudden severe chest pain, jaw pain, or left arm pain call 108 immediately.
FAQs
What blood tests should Indians get every year after 40?
The essential blood tests every year after 40 India are: HbA1c, fasting glucose, full lipid profile, CBC, TSH, Vitamin D, B12, creatinine with eGFR, urine microalbumin, LFT, uric acid, ferritin, ECG, and after 45 add hs-CRP, fasting insulin, PSA (men), and hormonal panels (women approaching menopause). A comprehensive package from an NABL lab covering these costs ₹2,500–₹4,500.
Why does the blood test panel expand after 40 in India?
Blood tests every year after 40 India expand because this is when cardiovascular disease, diabetes, thyroid disorders, and cancers begin their steepest acceleration. CVD prevalence rises from 22% in the 45–54 age group to 38% by 70. Most of these conditions are silent for years annual blood testing after 40 is the only reliable way to detect them before a crisis.
How much does the annual blood test panel cost after 40 in India?
A comprehensive annual blood test panel for Indians above 40 including HbA1c, lipid profile, CBC, TSH, Vitamin D, B12, liver and kidney function, iron studies, hs-CRP, and ECG costs approximately ₹2,500–₹4,500 at NABL labs. Home collection is free from most national labs. Section 80D deduction reduces effective cost further.
Do I need a prescription for blood tests after 40 in India?
No. Most routine blood tests can be booked directly at NABL-certified labs without a prescription through Dr. Lal PathLabs, SRL, Thyrocare, Redcliffe, Healthians, or PharmEasy Labs. After receiving results, consult your GP to interpret them in the context of your full medical history.
Is it safe to get all these blood tests on the same day?
Yes. All the annual blood tests recommended for adults above 40 can be collected in a single sample draw a few tubes of blood collected in one session, requiring 8–12 hours of fasting. The phlebotomist from any home-collection service can collect all required samples in 10–15 minutes. The total time investment is one fasting morning.
Download Seht — free on iOS and Android
Your annual blood test results after 40 are only useful if you can compare them year-over-year. Seht stores every report from Dr. Lal, SRL, Thyrocare, or any NABL lab in your family's secure health profiles. See whether your HbA1c is creeping up, your Vitamin D is improving, or your creatinine is trending in the wrong direction.
Download free:
Sources and references
ICMR — National guidelines for non-communicable disease screening in India. https://icmr.gov.in
Wiley — Cardiovascular diseases among Indian older adults. https://onlinelibrary.wiley.com/doi/10.1155/2024/6894693
Metropolis Healthcare — Preventive health checkup packages 2026. https://www.metropolisindia.com
Disclaimer: This blog is for informational purposes only and is not medical advice. Seht helps families stay informed, but is not a substitute for professional healthcare guidance.





Comments